English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Dose-Dependent Effects of Intranasal Insulin on Resting-State Brain Activity

MPS-Authors
/persons/resource/persons84145

Pohmann,  R
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;
Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons84187

Scheffler,  K
Max Planck Institute for Biological Cybernetics, Max Planck Society;
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

External Resource

Link
(Any fulltext)

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Kullmann, S., Veit, R., Peter, A., Pohmann, R., Scheffler, K., Häring, H.-U., et al. (2018). Dose-Dependent Effects of Intranasal Insulin on Resting-State Brain Activity. Journal of Clinical Endocrinology and Metabolism, 103(1), 253-262. doi:10.1210/jc.2017-01976.


Cite as: https://hdl.handle.net/21.11116/0000-0001-7D31-C
Abstract
Context
Insulin action in the human brain influences eating behavior, cognition, and whole-body metabolism. Studies investigating brain insulin rely on intranasal application.
Objective
To investigate effects of three doses of insulin and placebo as nasal sprays on the central and autonomous nervous system and analyze absorption of insulin into the bloodstream.
Design, participants and methods
Nine healthy men received placebo, 40U, 80U and 160U insulin spray in randomized order. Before and after spray, brain activity was assessed by functional magnetic resonance imaging and heart rate variability (HRV) was assessed from ECG. Plasma insulin, C-peptide, and glucose were measured regularly.
Results
Nasal insulin administration dose-dependently modulated regional brain activity and the normalized high-frequency component of the HRV. Post-hoc analyses revealed that only 160U insulin showed a significant difference from placebo. Dose-dependent spill-over of nasal insulin into the bloodstream was detected. The brain response was not correlated with this temporary rise in circulating insulin.
Conclusions
Nasal insulin dose-dependently modulated regional brain activity with the strongest effects after 160 U. However, this dose was accompanied by a transient increase in circulating insulin concentrations due to a spillover into circulation. Our current results may serve as a basis for future studies with nasal insulin to untangle brain insulin effects in health and disease.